Wilkinson Global Asset Management’s Idexx Laboratories IDXX Stock Holding History

Wilkinson Global Asset Management’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-3,155	Closed	-$1.32M	–	78
2025 Q1	$1.32M	Buy	3,155 +125	+4%	+$54.3K	0.08%	40
2024 Q4	$1.25M	Hold	3,030	–	–	0.08%	42
2024 Q3	$1.53M	Buy	3,030 +505	+20%	+$245K	0.09%	42
2024 Q2	$1.23M	Hold	2,525	–	–	0.08%	42
2024 Q1	$1.36M	Hold	2,525	–	–	0.09%	40
2023 Q4	$1.4M	Hold	2,525	–	–	0.1%	39
2023 Q3	$1.1M	Hold	2,525	–	–	0.08%	42
2023 Q2	$1.27M	Hold	2,525	–	–	0.1%	40
2023 Q1	$1.26M	Hold	2,525	–	–	0.1%	40
2022 Q4	$1.03M	Buy	2,525 +505	+25%	+$196K	0.09%	42
2022 Q3	$658K	Sell	2,020 -5	-0.2%	-$1.84K	0.06%	50
2022 Q2	$710K	Sell	2,025 -2,895	-59%	-$1.18M	0.06%	50
2022 Q1	$2.69M	Hold	4,920	–	–	0.17%	37
2021 Q4	$3.24M	Sell	4,920 -835	-15%	-$524K	0.18%	36
2021 Q3	$3.58M	Buy	5,755 +10	+0.2%	+$6.72K	0.22%	34
2021 Q2	$3.63M	Hold	5,745	–	–	0.21%	35
2021 Q1	$2.81M	Buy	+5,745	New	+$2.88M	0.18%	37

Other funds holding IDXX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Polen Capital Management Boca Raton, Florida $14.5B AUM 5.7% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Wilkinson Global Asset Management's IDXX Position: Q2 2025 in Review

Wilkinson Global Asset Management sold out of Idexx Laboratories (IDXX) in Q2 2025, closing a stake of 3,155 shares — an estimated $1.32M sold.

Wilkinson Global Asset Management first reported a position in IDXX in Q1 2021 and held it in 17 quarters. The position peaked at $3.63M in Q2 2021. 1,234 funds tracked by Wall St. Rank hold IDXX as of Q2 2025.

Wilkinson Global Asset Management reported no remaining Idexx Laboratories position as of Q2 2025 after selling out during the quarter.
Wilkinson Global Asset Management sold 3,155 Idexx Laboratories shares in Q2 2025, an estimated $1.32M.
Wilkinson Global Asset Management first reported a position in Idexx Laboratories in Q1 2021 and held it in 17 quarters.
Wilkinson Global Asset Management's Idexx Laboratories position peaked at $3.63M in Q2 2021.
1,234 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2025.

Based on Wilkinson Global Asset Management's 13F filing for Q2 2025, filed 11 Aug 2025.